Dr Martin's research interests are closely linked to her clinical experience and reflect her aim to pursue innovative science that improves patient care.
Neuroendocrine tumour biomarkers
Her experience as clinical advisor to the ICHNT Supraregional Assay Service for Neuroendocrine Tumour Markers and role as one of the lead clinicians for ICHNT Neuroendocrine Tumour Service has highlighted the clinical need for more specific diagnostic and prognostic markers for neuroendocrine tumours.
She has developed a clinical research programme to characterise existing and identify novel neuroendocrine tumour biomarkers.
She has established successful collaborations with Prof M.Caplin, UCL, Prof D. Cunningham, Royal Marsden Hospital, in addition to collaborations with colleagues within Imperial College and ICHNT (Dr R Sharma, Medical Oncology, Dr R Dina, Histopathology).
This research programme has been awarded a number of competitive grants. Publications from this programme has led to the revision of current ICNHT protocols for investigation of neuroendocrine tumours.
Dr Martin is lead clinician for the ICHNT Pituitary Service and runs a weekly specialist pituitary clinic. Her clinical experience has highlighted the need to improve investigation and management of pituitary disease. She has been local PI for several multicentre studies of pituitary disease and the findings from these studies have resulted in publications. Based on her publication record and experience in the management of pituitary disease, she has been an invited;
- Assessor of all pituitary abstracts submitted to international Society for Endocrinology meeting (2008-present), selecting those suitable for poster or oral presentation, and selecting prize-winning poster presentations at the meeting,
- Reviewer for Clinical Endocrinology and JCEM (2010 onwards),
- Editor for Prolactinoma http://bmj.bestpracticecom (2012),
- Speaker at The Endocrine Society 94th Annual Meeting, Houston, USA ‘Controversial Issues in Cushing’s syndrome: How should we screen?’ (2012).
- Local PI for multicentre national study of pegvisomant and cabergoline in combination in the management of acromegaly (2009-2011)